NextVivo is an ambitious start-up company, located in Stanford Research Park. We are working to leverage the power of the breakthrough technology of human derived immune organoids, invented by our co-founders Mark Davis and Calvin Kuo at Stanford University. We are focused on using this immune-competent organoid platform to develop novel drugs and cell therapies to fight human diseases, including cancer, infectious disease, and autoimmune disorders.
| Website | http://nextvivo.bio |
| Employees | 2 (0 on RocketReach) |
| Address | 3160 Porter Dr, Palo Alto, California 94304, US |
| Industry | Biotechnology Research |
| Keywords | Immune System, In Vitro Models, Organoid Technology, Cell Culture, Immunology Research, Disease Modeling, Biotechnology, Pharmaceutical Research, Drug Discovery, Biomedical Research, Therapeutic Development, Regenerative Medicine, Precision Medicine, Cancer Research, Immunotherapy, Infectious Disease |
| Competitors | GRAIL, Guardant Health, Foundation Medicine, Caris Life Sciences, Exact Sciences, Natera, OncoOne, Tempus Labs, Inc., Wiley, Biodesix, Inc. +36 more (view full list) |
Looking for a particular NextVivo employee's phone or email?
NextVivo Questions
NextVivo is based in Palo Alto, California.
Related Companies
G2Crowd Trusted
300K+
Plugin Users
